Skip to Content


Importer of Controlled Substances Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Notice of registration.


Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

End Preamble Start Supplemental Information


The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

CompanyFR docketPublished
Cambridge Isotope Laboratories82 FR 19083April 25, 2017.
Janssen Ortho LLC82 FR 19083April 25, 2017.
Galephar Pharmaceutical Research, Inc.82 FR 23069May 19, 2017.
Mallinckrodt LLC82 FR 23071May 19, 2017.
Cerilliant Corporation82 FR 25335June 1, 2017.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Start Signature

Dated: August 2, 2017.

Demetra Ashley,

Acting Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-16698 Filed 8-7-17; 8:45 am]